Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma. - Odeniyide P; Skaist A; Fenner E; Amirkhanian H; Baker A; Lisok A; Zhang L; Fridman LB; Rojas RI; Hebron KE; Davis C; Zhang X; et al. (Cancer research, 2026)